S.Res. 447

[Congressional Bills 119th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 447 Agreed to Senate (ATS)]

<DOC>

119th CONGRESS
1st Session
S. RES. 447

Designating September 25, 2025, as ``National Ataxia Awareness Day'', 
and raising awareness of ataxia, ataxia research, and the search for a 
cure.

_______________________________________________________________________

IN THE SENATE OF THE UNITED STATES

October 9, 2025

Mrs. Hyde-Smith (for herself, Mr. Murphy, and Mrs. Capito) submitted 
the following resolution; which was considered and agreed to

_______________________________________________________________________

RESOLUTION

Designating September 25, 2025, as ``National Ataxia Awareness Day'', 
and raising awareness of ataxia, ataxia research, and the search for a 
cure.

Whereas ataxia is a clinical manifestation indicating degeneration or 
dysfunction of the brain that negatively affects the coordination, 
precision, and accurate timing of physical movements;
Whereas ataxia can strike individuals of all ages, including children;
Whereas the term ``ataxia'' is used to classify a group of rare, inherited 
neurodegenerative diseases including--

(1) ataxia telangiectasia;

(2) episodic ataxia;

(3) Friedreich's ataxia; and

(4) spinocerebellar ataxia;

Whereas there are many known types of genetic ataxia, but the genetic basis for 
ataxia in some patients is still unknown;
Whereas all inherited ataxias affect fewer than 200,000 individuals in the 
United States, and therefore, are recognized as rare diseases under the 
Orphan Drug Act (Public Law 97-414; 96 Stat. 2049);
Whereas some genetic ataxias are inherited in an autosomal dominant manner while 
others are inherited in an autosomal recessive manner;
Whereas ataxia symptoms can also be caused by noninherited health conditions and 
other factors, including stroke, tumor, cerebral palsy, head trauma, 
multiple sclerosis, alcohol addiction or misuse, and certain 
medications;
Whereas ataxia can present physical, psychological, and financial challenges for 
patients and their families;
Whereas symptoms and outcomes of ataxia progress at different rates and can 
include--

(1) lack of coordination;

(2) slurred speech;

(3) cardiomyopathy;

(4) scoliosis;

(5) eye movement abnormalities;

(6) difficulty walking;

(7) tremors;

(8) trouble eating and swallowing;

(9) difficulties with other activities that require fine motor skills; 
and

(10) death;

Whereas many patients with ataxia require the use of assistive devices, such as 
wheelchairs and walkers, to aid in their mobility, and many individuals 
with ataxia may need physical and occupational therapy;
Whereas few treatments and no cures have been approved for ataxia; and
Whereas clinical research to develop safe and effective treatments for ataxia is 
ongoing: Now, therefore, be it
Resolved, That the Senate--
(1) recognizes the need for greater public awareness of 
ataxia;
(2) designates September 25, 2025, as ``National Ataxia 
Awareness Day'';
(3) supports the goals of National Ataxia Awareness Day, 
which are to--
(A) raise awareness of the causes and symptoms of 
ataxia among the general public and health care 
professionals;
(B) improve diagnosis of ataxia and access to care 
for patients affected by ataxia; and
(C) accelerate ataxia research, including on safe 
and effective treatment options and, ultimately, a 
cure;
(4) recognizes the individuals in the United States who 
face challenges due to having ataxia, and the families of those 
individuals; and
(5) encourages States, territories, and localities to 
support the goals of National Ataxia Awareness Day.
<all>